
Prescription Required







Authentic Product

India's Leading Generic Pharmacy

Secure Payment
By INTAS PHARMACEUTICALS LIMITED
MRP
₹
96.18
₹81.75
15 % OFF
₹8.18 Only /
TabletCheck Delivery
--
Composition
Content Reviewed By:
Dr. Manoj Shah
, (MBBS)
Written By:
Ms. Priyanka Shah
, (B.Pharm)
Most side effects are temporary and disappear as your body adapts to REXIPRA 10MG TABLET 10'S. However, if any side effects persist or cause concern, it's important to consult your doctor.

Other medical conditions and drug interactions
Use under medical supervisionRexipra should be used cautiously in patients with a history of bipolar disorder, as antidepressants can precipitate manic or hypomanic episodes. Screening for bipolar disorder before initiation is advisable.
Usually, it will take about 2-4 weeks before you start feeling better, however, full benefits may take a little longer. Therefore, do not stop taking REXIPRA 10MG TABLET 10'S without consulting your doctor. Talk to your doctor if taking the medicine does not make you feel better or you feel worse even after taking the medicine.
The most common side effects of REXIPRA 10MG TABLET 10'S are headache and nausea. Other common side effects include blocked or runny nose, decreased or increased appetite, anxiety, restlessness, and abnormal dreams. You may also experience sleepiness or difficulty falling asleep, dizziness, yawning, tremors, diarrhea, or constipation. Other side effects of REXIPRA 10MG TABLET 10'S may be vomiting, dry mouth, increased sweating, fatigue, fever, increase in weight, and pain in muscles and joints. Using this medicine may even cause delayed ejaculation, problems with erection, decreased sexual drive and women may experience difficulty in achieving orgasm.
REXIPRA 10MG TABLET 10'S is used to treat depression and anxiety disorders such as social phobia, anxiety disorder, panic attacks, and obsessive-compulsive disorder.
The use of REXIPRA 10MG TABLET 10'S in children, adolescents, and young adults may increase their risk of experiencing suicidal tendencies. You should always discuss the risks and benefits of taking REXIPRA 10MG TABLET 10'S with your doctor before taking it. Remember that children younger than 12 years of age should not be given REXIPRA 10MG TABLET 10'S.
It is usually recommended to take REXIPRA 10MG TABLET 10'S once a day in the morning since it can keep you awake if taken late at night. You can take it with or without food. You should prefer to take it at the same time each day so that you remember to take it.
REXIPRA 10MG TABLET 10'S should not be stopped abruptly as it may cause withdrawal symptoms. Though the withdrawal symptoms are usually mild and disappear within 2 weeks, it is not recommended to stop it without consulting your doctor. You should rather consult your doctor who will reduce the dose gradually.
The withdrawal symptoms include dizziness, sleep disturbances like vivid dreams, nightmares and inability to sleep, anxiety, and headaches. You may also get burning sensations and electric shock sensations. Withdrawal symptoms may also include nausea, sweating including night sweats, restlessness or agitation, tremors, confusion, irritability, diarrhea, visual disturbances, and palpitations.
If you accidentally take more than the recommended dose of REXIPRA 10MG TABLET 10'S, seek immediate medical attention in a nearby hospital or call your doctor immediately. The symptoms of overdose dizziness, tremor, agitation, convulsion, coma, nausea, and vomiting. You may also experience changes in heart rhythm, decreased blood pressure, and change in body fluid/salt balance.
Rexipra is a prescription antidepressant medicine that contains escitalopram oxalate as its active ingredient. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder and various anxiety disorders by increasing serotonin levels in the brain.
Rexipra is commonly prescribed for major depressive disorder and generalized anxiety disorder. Depending on clinical judgment and local approvals, it may also be used for social anxiety disorder, panic disorder (with or without agoraphobia), and obsessive‑compulsive disorder. The exact indication for an individual patient should be confirmed with the prescribing doctor.
Rexipra works by selectively inhibiting the reuptake of serotonin (5‑HT) into presynaptic nerve terminals in the brain. This increases the availability of serotonin in the synaptic cleft, which is believed to help regulate mood, reduce anxiety, and improve other symptoms associated with depressive and anxiety disorders. The effect develops gradually over several weeks.
Some patients may notice partial improvement in symptoms such as sleep, appetite, or anxiety within 1–2 weeks of starting Rexipra, but full antidepressant and anxiolytic effects typically take 4–6 weeks or longer. Response time varies between individuals. Treatment should not be stopped prematurely without consulting the doctor, even if improvement is not immediately apparent.
Common side effects of Rexipra include nausea, headache, dry mouth, increased sweating, dizziness, fatigue, insomnia or sleepiness, and gastrointestinal changes such as diarrhea or constipation. Sexual side effects such as reduced libido, delayed ejaculation, or difficulty achieving orgasm can also occur. Many of these effects are mild and may lessen with continued use, but persistent or troublesome symptoms should be discussed with a healthcare professional.
Rexipra is not considered addictive in the way that benzodiazepines or opioids are, but stopping it abruptly can lead to discontinuation symptoms. These may include dizziness, tingling sensations, sleep disturbances, irritability, anxiety, nausea, and flu‑like symptoms. To minimize these effects, Rexipra should be tapered gradually under medical supervision rather than stopped suddenly.
Rexipra should not be used concurrently with monoamine oxidase inhibitors (MAOIs) or within the recommended washout period before or after MAOI therapy, due to the risk of serious serotonin syndrome. Combining Rexipra with other serotonergic antidepressants (such as other SSRIs, SNRIs, or certain tricyclics) requires careful medical supervision and is generally avoided unless specifically justified. Patients must inform their doctor about all antidepressants and other medicines they are taking.
Like other antidepressants, escitalopram in Rexipra has been associated with an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, particularly during the initial weeks of treatment or after dose changes. Close monitoring by healthcare professionals and caregivers is essential. Any new or worsening suicidal thoughts, self‑harm behavior, severe agitation, or unusual mood changes should be reported immediately.
If you miss a dose of Rexipra, take it as soon as you remember unless it is close to the time of your next scheduled dose. If it is almost time for the next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. If you frequently forget doses, discuss strategies for adherence with your healthcare provider.
Rexipra should generally be avoided in individuals with known hypersensitivity to escitalopram or any component of the formulation, those taking MAOIs or within the required washout period, and patients with certain congenital or documented QT interval prolongation or significant arrhythmias unless the benefit clearly outweighs the risk. Caution and individualized assessment are required in patients with bipolar disorder, seizure disorders, significant liver or kidney impairment, bleeding disorders, or those taking medicines that affect heart rhythm or bleeding risk.
Stopping Rexipra should always be done in consultation with your doctor. Even after symptoms improve, treatment is often continued for several months to reduce the risk of relapse. Abrupt discontinuation can lead to withdrawal‑like symptoms and possible return or worsening of the underlying condition. Your doctor will usually recommend a gradual dose reduction plan tailored to your situation.
Awesome
Pankaj Patel
•
Reviewed on 13-06-2023
(5/5)
Should display more medical verities.
Ronak Ankola
•
Reviewed on 25-07-2023
(2/5)
Very cheap, helpful, friendly service
Milind Patel
•
Reviewed on 10-02-2023
(5/5)
Excellent service and support 24/7 Supportive and co operative staff.
Ajay Nayak Dhadkan
•
Reviewed on 13-01-2024
(5/5)
Best
Vishva Ukani
•
Reviewed on 07-01-2024
(5/5)
INTAS PHARMACEUTICALS LIMITED
Country of Origin -
India
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered

Authentic Products
All WHO-GMP Certified Medicines
©2025 Medkart Pharmacy. All Rights Reserved